BioSpace News Archive

Turbine, a computational biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd to identify and validate novel targets within one of Ono’s priority domains of cancer biology.

Genascence Corporation announced that data from the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis demonstrated that it was safe and well tolerated.

Endogena Therapeutics Inc., a pioneering biotech company dedicated to revolutionizing regenerative medicine, is proud to announce a significant achievement that holds the promise of transforming lives.

Life Molecular Imaging and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® has received regulatory approval from National Medical Products Administration in China.

ProfoundBio announced that management will be participating in one-on-one meetings with investors at the Wells Fargo 2023 Virtual Private Biotech Symposium on Wednesday, November 1, 2023 and at the Piper Sandler 35th Annual Healthcare Conference from November 28 – November 30, 2023.

ZAP Surgical, a leading innovator in the field of surgical robotics, announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan.

Vektor Medical, a pioneer in arrhythmia care and developer of vMap®, the world’s first technology to accurately map arrhythmias using the patient’s 12-lead ECG data, announces the American Medical Association CPT Editorial Panel has approved a new Category III CPT code for the use of vMap’s noninvasive arrhythmia analysis.

Q3 results reflect strong operational execution, restructuring actions, and proactive spending discipline.

Caris Life Sciences® announced a new agreement with Moderna in support of Moderna’s oncology and novel therapeutics initiatives.

Sage Therapeutics, Inc. announced that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.